https://www.selleckchem.com/products/ml349.html
Prasugrel is an antiplatelet agent in the thienopyridine group. Prasugrel is used to decrease the rate of cardiovascular events in patients with acute coronary syndrome (ACS) who are undergoing percutaneous coronary intervention. Prasugrel has approval for medical management of patients with unstable angina or non-ST elevation myocardial infarction (NSTEMI), and patients with ST-elevation myocardial infarction (STEMI) when managed with percutaneous coronary intervention. Prasugrel is an alternative agent to clopidogrel, which has greater